Hematological Malignancy: Clinical Trials

2 trials for Hematological Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 11Terminated 1

Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
BMS-986253 - Solid Tumor, Sars-CoV2
Phase 2TerminatedColumbia University432020-04-162025-05-22
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
MT-3724 Phase 1, MT-3724 Phase 2 - Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell
Phase 1 / Phase 2TerminatedMolecular Templates, Inc.382015-02-012022-08-18

Narrower conditions

Hematologic Neoplasms (2)  ·  COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms by Site (2)  ·  Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Lung Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)

Interventions

HuMax-IL8 (1)

Sponsors

Columbia University (1)  ·  Molecular Templates, Inc. (1)

Countries

United States (2)  ·  Belarus (1)  ·  Canada (1)  ·  Georgia (1)  ·  Israel (1)  ·  Moldova (1)  ·  Poland (1)  ·  Serbia (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Mark N Stein, MD (1)